Search results
Results From The WOW.Com Content Network
Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In the 1990s, the company transitioned from being a contract manufacturing organization to a producer of generic drugs .
Namita Thapar (née Mehta; born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. [1] She is the Executive director of Emcure Pharmaceuticals. [2]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their joint work on a COVID-19 shot, the ...
First Financial Bank (Nasdaq: FFBC), a regional bank headquartered in Cincinnati; has client servicing operations in the Tri-County, northern Cincinnati metropolitan area; founded in 1863, it has the eighth oldest national bank charter and has locations in Southwest Ohio, Northern Kentucky, and throughout Indiana; acquired Irwin Financial Corp ...
I have just modified 4 external links on Emcure Pharmaceuticals. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals and former president of the healthcare consulting firm MarketMaster. The company remains privately held.
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drug developer Map Pharmaceuticals (NAS: MAPP) has received ...